EntryPoint Capital’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
EntryPoint Capital's ATRC Position: Q2 2026 in Review
EntryPoint Capital increased its AtriCure (ATRC) stake by 55% in Q2 2026, buying an estimated $308K and bringing the position to 30,831 shares worth $863K. The position accounts for 0.21% of the portfolio, ranked #118.
EntryPoint Capital first reported a position in ATRC in Q4 2023 and has held it in 10 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- EntryPoint Capital held 30,831 shares of AtriCure worth $863K as of Q2 2026.
- EntryPoint Capital bought 10,950 AtriCure shares in Q2 2026, an estimated $308K.
- AtriCure made up 0.21% of EntryPoint Capital's portfolio in Q2 2026, its #118 holding.
- EntryPoint Capital first reported a position in AtriCure in Q4 2023 and has held it in 10 quarters since.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.